Malignant melanoma. REPORT OF A MEETING OF PHYSICIANS AND SCIENTISTS, UNIVERSITY COLLEGE LONDON MEDICAL SCHOOL

The Lancet

Volumn 340, Issue 8825, 1992, Pages 948-951

  Ledermann, J A ^a   Dubois, D ^a   Stauss, H ^a   Link, E M ^b   Collins, M ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ALKALOID; CISPLATIN; DACARBAZINE; NITROSOUREA; TAMOXIFEN; VINDESINE;

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALE; MELANOMA; METASTASIS; MORTALITY; PROGNOSIS; IMMUNOTHERAPY; MEDICAL RESEARCH; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CASE REPORT; FEMALE; HUMAN; MALE; MELANOMA; PROGNOSIS;

EID: 0027122370     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)92825-Z     Document Type: Article

References (34)

1. Cutaneous malignant melanoma, Scotland, 1979-89
2. A comparison of prognostic factors and surgical results in 1786 patients with localized (stage 1) melanoma treated in Alabama USA and New South Wales Australia
3. Melanoma
4. The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma
5. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study
6. High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation Group
7. The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma.
8. Treatment of metastatic melanoma with dacarbazine plus tamoxifen
9. A phase II study of taxol in patients with malignant melanoma
10. Final report of the French multicenter phase II study of nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases
11. Adjuvant immunotherapy with BCG in the treatment of regionallymph node metastases from malignant melanoma
12. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group
13. Melanoma antigens: immunological and biological characterization and clinical significance
14. Imaging of melanoma with I-131 labelled monoclonal antibodies
15. The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma
16. Diagnosis of and therapy for solid tumors with radiolabelled antibodies and immune fragments
17. Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin
18. A new radioactive drug selectively accumulating in melanoma cells
19. 211At-methylene blue for pigmented melanoma in an animal model system
20. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases
21. Recombinant leukocyte A interferon (y IFN-αA) in the treatment of disseminated malignant melanoma: analysis of complete and long-term responding patients
22. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
23. The immunotherapy and gene therapy of cancer
24. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma
25. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
26. Human gene therapy comes of age
27. Interleukin 2 gene transfer into tumour cells abrogates tumorigenicity and induces protective immunity
28. Interleukin-2 production by tumour cells bypasses T helper function in the generation of an antitumor response
29. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4
30. Retroviral vector-mediated y interferon gene transfer into tumor cells generated potent and long lasting antitumour immunity
31. Links between exposure to ultraviolet radiation and skin cancer
32. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction